Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable well-doucmented study report which meets basic scientific principles.
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1974

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Human embryonic lung culture cells (WI-38) were exposed to calcium silicate for 24-48 hours. Anaphase preparations were then and analysed microscopically for chromosomal aberrations
GLP compliance:
not specified
Type of assay:
other: cytogenetic assay

Test material

Constituent 1
Reference substance name:
Calcium silicate
EC Number:
233-250-6
EC Name:
Calcium silicate
Cas Number:
10101-39-0
IUPAC Name:
calcium oxosilanediolate
Details on test material:
- Name of test material (as cited in study report): Silene (calcium silicate, hydrated)

Method

Species / strain
Species / strain / cell type:
mammalian cell line, other: WI-38
Details on mammalian cell type (if applicable):
- Type and identity of media: minimal essential medium, with 1% glutamine, 200 U/ml penicillin, 200 µg/ml streptopmycin, 15% foetal calf serum
- Properly maintained: yes
Test concentrations with justification for top dose:
1, 10, 100 µg calcium silicate / ml
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: saline
Controls
Untreated negative controls:
yes
Remarks:
saline
Positive controls:
yes
Positive control substance:
triethylenemelamine
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Preincubation period: 24 h
- Exposure duration: 24-48 h
- Expression time (cells in growth medium): 48-72 h
- Fixation time (start of exposure up to fixation or harvest of cells): 24-48 h


NUMBER OF REPLICATIONS: no data

NUMBER OF CELLS EVALUATED: 100

DETERMINATION OF CYTOTOXICITY
- Method: mitotic index

Evaluation criteria:
Calculation of % cells with chromosomal aberrations. Comparison with negative and positive controls.
% cells with acentrig fragments, % cells with bridges, % multipolar cells and % cells with other aberrations were also calculated.
Statistics:
No data

Results and discussion

Test results
Species / strain:
mammalian cell line, other: WI-38
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
not examined
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
No aberrations were observed due to calcium silicate exposure.
The mitotic index was not affected.

Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'. Remarks: 1530

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

Calcium silicate did not induce chromosomal aberrations in human embryonic lung cultures (WI-38).
Executive summary:

The potential of calcium silicate (1 -100 µg/ml) to induce chromosomal aberrations was tested in vitro with human embryonic lung cultures (WI-38) (Litton 1974). No inductions of aberrations were seen, indicating that calcium silicate is not genotoxic in vitro.